About

16 March 2021

Jubilant Radiopharma and Isotopia Molecular Imaging Enter into a Strategic Partnership to Further Advance the Field of Radiotherapeutics

Isotopia Molecular Imaging Limited (Isotopia) and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, have entered into a strategic commercial partnership.

4 November 2020

Jubilant Radiopharma and SOFIE Biosciences Ink Strategic Partnership Deal to Further Advance the Field of Molecular Imaging & Therapeutics

31 August 2020

Eckert & Ziegler‘s GalliaPharm® to be distributed by Jubilant Radiopharma in Canada

10 August 2020

Jubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization Partnership

March 18th, 2020

OUR COMPANY RESPONSE TO COVID-19

February 17th, 2020

JUBILANT RECEIVES FAVORABLE RULINGS FROM THE U.S. PATENT OFFICE INVALIDATING BRACCO RUBIDIUM-INFUSION-SYSTEM PATENTS

January 29th, 2020

Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime® a Product Used to Diagnose Intra-Abdominal Infection and Inflammatory Bowel Disease

December 11th, 2019

FAVORABLE RULING FROM THE U.S. COURTS FOR RUBY-FILL®

October 25th, 2019

JUBILANT AWARDED PREMIER PURCHASING AGREEMENT

October 03rd, 2019

JUBILANT TO DISTRIBUTE STRONTIUM-89 CHLORIDE INJECTION USP IN THE U.S.

August 28th, 2019

QUALITY AND SAFETY IS AT THE CORE OF WHAT WE DO

August 12th, 2019

ITC FOUND THAT JUBILANT IMPORTATION AND SALE OF RUBY-FILL IN THE U.S. DOES NOT VIOLATE SECTION 337 OF THE TARIFF ACT OF 1930

July 23rd, 2019

IMPORTANT INFORMATION FOR CANADIAN NUCLEAR PHARMACISTS

July 19th, 2019

Important information for U.S. nuclear pharmacists and commercial radiopharmacies

June 17th, 2019

Introducing Jubilant Radiopharma

June 06th, 2019

RUBY Rubidium Elution System™ receives CE Mark Certificate

March 26th, 2019

New and Important Safety Information as Requested by the FDA

February 08th, 2019

Campaign to Support FDA Approved Products

September 28th, 2018

Family Health Campaign

August 13th, 2018

Jubilant initiates I-131 MIBG OPTIMUM Trial

April 06th, 2018

Important Customer Communication

December 30th, 2017

JDI receives FDA approval for new pulmonary indications for DRAXIMAGE® DTPA

November 06th, 2017

JDI to attend Miami Thyroid Oncology Symposium 2018

October 27th, 2017

Jubilant DraxImage receives FDA approval for 12-Hour shelf-life for DRAXIMAGE® MAA

September 28th, 2017

Jubilant DraxImage receives approval from Health Canada for the RUBY Elution System™ (RbES)

September 27th, 2017

ASNC 2013 in Chicago, IL

May 05th, 2017

Jubilant Pharma to acquire Triad Isotopes

January 19th, 2017

JDI participates to SNMMI Mid-Winter in Phoenix Arizona

April 09th, 2017

Jubilant DraxImage Appoints New Sales and Business Operations VP

October 21st, 2016

Michael Rossi: New President of Jubilant DraxImage.

October 03rd, 2016

JDI RECEIVES FDA APPROVAL for products

September 30th, 2016

No impact on I-131 supply from Chalk River shutdown

May 12th, 2016

JDI and CYC Licensing Agreement Update

May 03rd, 2016

Not all Iodine-131 is created equal

January 06th, 2016

Count On It DRAXIMAGE® MAA 350K Particles Campaign

December 03rd, 2015

Canada- Radioactive Iodine in Differentiated Thyroid Cancer; Patient Video

December 03rd, 2015

USA – Radioactive Iodine in Differentiated Thyroid Cancer; Patient Video

October 09th, 2015

Jubilant DraxImage launches HICON® in Colombia

September 14th, 2015

JDI-Cyclopharm Technegas Announcement

September 11th, 2015

September is Thyroid Cancer Awareness month

September 01st, 2015

ASNC 2015 – Washington, DC, Sept. 17-20 – booth 801

July 07th, 2015

New Endocrine Brand Portfolio Manager

May 19th, 2015

SNMMI 2015 – Baltimore, MD June 6 to 9 – Booth 853

May 08th, 2015

Canada: temporary shortage of Xenon-133

April 20th, 2015

Jubilant DraxImage Files Citizen Petition with the FDA

December 08th, 2014

New Lung Imaging Portfolio Manager

November 20th, 2014

RSNA 2014: Chicago, IL

October 20th, 2014

New Director – Manufacturing Operations

September 22nd, 2014

ASNC 2014, Boston, MA

August 19th, 2014

New Director – Commercial Operations for Latin America

May 15th, 2014

MAA Pricing: FAQ

May 12th, 2014

New USA Sales Director

April 18th, 2014

MAA Pricing: Investing in the Future of MAA & DTPA

March 01st, 2014

Action to ensure sustainability and continuity of supply of MAA/DTPA in USA

January 13th, 2014

Jubilant DraxImage Appoints New Marketing Director

November 08th, 2013

Japanese SNM 2013 in Fukuoka, Japan

September 06th, 2012

ASNC 2012 in Baltimore, MD